GamCath Short-Term Catheters

Advancing catheter technologies to improve therapy access for acute patients

More access options to optimize therapy delivery

Catheter choices may help optimize therapy delivery and streamline workflows in the ICU. Based on our expertise in acute dialysis, Vantive has developed a broad range of GamCath catheters that combine flexibility and innovation to help provide optimal patient care. The line of GamCath catheters includes Conventional, HighFlow, and Dolphin Protect coating options to meet the unique needs of adult and pediatric patients in the ICU.

Compatible Products

Solutions

Conventional catheters designed for flexibility and safety

With a wide range of options, GamCath conventional catheters are designed for treatment flexibility and patient safety when short-term vascular access is needed to perform extracorporeal blood purification therapies.

 

The GamCath catheter hub is fixed and molded to the lumen, creating a seamless passageway to the extensions.1 The catheters are made of thermosensitive DEHP-free polyurethane material.1

 

Color-coded safety clamps with ID inserts are printed with information on size, length and priming volumes.1

GamCath: Conventional catheters designed for flexibility and safety

HighFlow catheters help optimize access during acute therapies

GamCath HighFlow short-term catheters feature a unique lumen design for increased blood flow and optimized access in acute therapies.

GamCath: high-flow vs. conventional double-D

Increased blood flow

The GamCath HighFlow catheter’s kidney-shaped lumen design with larger arterial lumen may ease arterial pressure, allowing for improved blood flow.2

GamCath design

Reduced risk of clotting

The staggered double-lumen tip configuration of the GamCath HighFlow catheter is free of side holes and may reduce the risk of clotting.3,4

Dolphin protective coating 

The GamCath HighFlow catheters with Dolphin Protect coating can help reduce bacterial colonization and thrombotic catheter complications for ICU patients.5,6

Vantive’s proprietary Dolphin Protect coating is a copolymer film with an antibacterial bismuth additive that is applied over the entire catheter.1 The copolymer layer locks in barium sulfate particles to help prevent catheter surface degradation.1,7

Supported by clinical evidence, GamCath HighFlow catheters with Dolphin Protect coating have the following features when compared to conventional, uncoated catheters.

  • Reduced bacterial colonization5

  • Lower rate of thrombotic catheter complications6

  • Improved bacteriological barrier6

Dolphin protective coating for reduced catheter complications

Supporting the needs of acute patients

The broad line of GamCath catheters is an integral part of Vantive’s comprehensive framework of products, services and support, specially developed for the needs of ICU professionals and their patients. GamCath catheters leverage Vantive’s long-standing leadership and expertise in critical care to help further maximize treatment options powered by our PrisMax and Prismaflex technology, all to support the individual needs of acute patients.

Related products

Important Safety Information

Please click here for important safety information.

Vantive, GamCath, Prismaflex, PrismaLung+ and PrisMax are trademarks of Vantive Health LLC or its affiliates.

References

  1. Vantive Health LLC. GamCath HighFlow Dolphin Catheter 510(k) Summary.

  2. Costantino et al, Dipartimento di Bioingegneria Politecnico di Milano, Italy. Modular and comparative CFD catheter analysis; Data available on file.

  3. Moore HL. Side holes at the tip of chronic hemodialysis catheters are harmful. J Vasc Access. 2001;2(1):8-16.

  4. Tal MG, Peixoto AJ, Crowley ST, Denbow N, Eliseo D, Pollak J. Comparison of side hole versus non side hole high flow hemodialysis catheters. Hemodial Int. 2006;10(1):63-67.

  5. Schindler R, Heemann U, Haug U, et al. Bismuth coating of non-tunneled haemodialysis catheters reduces bacterial colonization: a randomized controlled trial. Nephrol Dial Transplant. 2010;25:2651-2656.

  6. Meier P, Meier R, Turini P, Friolet R, Blanc E. Prolonged catheter survival in patients with acute kidney injury on continuous renal replacement therapy using a less thrombogenic micropatterned polymer modification. Nephrol Dial Transplant. 2011;26(2):628-35.

  7. Verbeke F, Haug U, Dhondt A, et al. The role of polymer surface degradation and barium sulphate release in the pathogenesis of catheter-related infection. Nephrol Dial Transplant. 2010;25:1207-1213.